A new clinical trial gets the green light as researchers from UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) investigate whether a common heart medication could help treat people living with the form of motor neurone disease known as Amyotrophic Lateral Sclerosis (ALS).
Associate Professor Shyuan Ngo, or "Shu" as she is widely known, has been walking the halls of UQ since 1999. She first arrived as an undergraduate student and is now a group leader at the AIBN, where she leads research into MND.
AIBN researcher Dr Sophia Luikinga is following in the footsteps of her MND research mentor after winning a prestigious fellowship to address the neurodegenerative condition from a new angle.
What can the metabolism of 606 people from China, the Netherlands and Australia tell us about the onset and progression of ALS? Turns out, quite a bit.
A healthy gut might be impacting the longevity of people living with Motor Neurone Disease (MND), according to new research from The University of Queensland.
